VivoSeq
Other

Aggression

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Aggression is an early-stage landscape with 0 programs across 1 company. The most active players are Supernus Pharmaceuticals, Inc..

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

58/100

Attrition Rate

33/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Supernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

15

clinical trials

Completed7 · 47%
Terminated4 · 27%
Unknown status2 · 13%
Withdrawn1 · 7%
Not yet recruiting1 · 7%

Clinical Trials

Trial Activity

15 trials

Inflammatory Challenge in Human Aggression.
Not yet recruiting·OOhio State University·Phase 2·NCT06665074·112 enrolled
Dialectical Behavioral Therapy Skills for Impulsive Aggression
Completed·—·N/A·NCT05351944·66 enrolled
Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1)
Completed·Supernus Pharmaceuticals, Inc. logoSupernus Pharmaceuticals, Inc.·Phase 3·NCT02618408·333 enrolled
Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)
Completed·Supernus Pharmaceuticals, Inc. logoSupernus Pharmaceuticals, Inc.·Phase 3·NCT02618434·297 enrolled
Treatment of Severe Childhood Aggression (The TOSCA Study)
Completed·—·Phase 4·NCT00796302·168 enrolled
Clozapine and Olanzapine Treatment of Aggression
Completed·NNathan Kline Institute for Psychiatric Research·N/A·NCT01123408·110 enrolled
Oxytocin, Alcohol Craving, and Intimate Partner Aggression
Completed·MMedical University of South Carolina·Phase 2·NCT03046836·200 enrolled
Risperidone Augmentation for Treatment-Resistant Aggression in ADHD
Completed·AArmenteros, Jorge L., M.D., P.A.·Phase 4·NCT00297739·25 enrolled
Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates
Terminated·UUniversity of Connecticut·N/A·NCT00203775
Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order
Terminated·UUMC Utrecht·Phase 4·NCT00282165·8 enrolled
Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 4)
Terminated·Supernus Pharmaceuticals, Inc. logoSupernus Pharmaceuticals, Inc.·Phase 3·NCT02691182·491 enrolled
Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD
Terminated·Supernus Pharmaceuticals, Inc. logoSupernus Pharmaceuticals, Inc.·Phase 2·NCT03638466·7 enrolled
Clozapine IM and Aggression in Schizophrenic Patients
Withdrawn·—·Phase 3·NCT00189995
Pilot Trial of Neural Correlates of Response to Treatment of PTSD-Associated Impulsive Aggression
Unknown status·MMichael E. DeBakey VA Medical Center·N/A·NCT00333931·12 enrolled
Neurokinin (NK) 1 Antagonist for Pathological Aggression for Harmful, Impulsive, and Self-/Aggressive Behaviour
Unknown status·SSt. Joseph's Healthcare Hamilton·Phase 1/2·NCT02989779·50 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)